{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T12:46:04Z","timestamp":1782477964314,"version":"3.54.5"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T00:00:00Z","timestamp":1359676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National key Science & Technology Specific Projects","award":["2011ZX09306"],"award-info":[{"award-number":["2011ZX09306"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Virological Methods"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1016\/j.jviromet.2012.10.002","type":"journal-article","created":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T23:01:01Z","timestamp":1351638061000},"page":"304-313","source":"Crossref","is-referenced-by-count":6,"title":["Identification of three H-2Kd restricted CTL epitopes of NS4A and NS4B protein from Yellow fever 17D vaccine"],"prefix":"10.1016","volume":"187","author":[{"given":"Weijun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghua","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviromet.2012.10.002_bib0005","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.4049\/jimmunol.0803903","article-title":"The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response","volume":"183","author":"Akondy","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0010","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.antiviral.2006.07.002","article-title":"DNA immunization with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb\/c mice","volume":"72","author":"Barfoed","year":"2006","journal-title":"Antivir. Res."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/biol.1997.0056","article-title":"Yellow fever vaccines","volume":"25","author":"Barrett","year":"1997","journal-title":"Biologicals"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev.ento.52.110405.091454","article-title":"Yellow fever: a disease that has yet to be conquered","volume":"52","author":"Barrett","year":"2007","journal-title":"Annu. Rev. Entomol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0025","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1016\/j.vaccine.2006.12.015","article-title":"17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, 12 September 2005","volume":"25","author":"Barrett","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0030","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.coi.2009.05.018","article-title":"Yellow fever vaccine \u2013 how does it work and why do rare cases of serious adverse events take place?","volume":"21","author":"Barrett","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0035","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1128\/JVI.02255-09","article-title":"Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaques","volume":"84","author":"Bonaldo","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0040","first-page":"8","article-title":"Localization of a T-cell epitope within the nucleocapsid protein of avian coronavirus","volume":"74","author":"Boots","year":"1991","journal-title":"Immunology"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0045","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cimid.2007.07.012","article-title":"Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines","volume":"31","author":"Brandler","year":"2008","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0050","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/infdis\/161.6.1134","article-title":"Immunogenicity of a purified fragment of 17D yellow fever envelope protein","volume":"161","author":"Brandriss","year":"1990","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0055","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1099\/0022-1317-67-2-229","article-title":"Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses","volume":"67","author":"Brandriss","year":"1986","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0060","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00705-011-0927-x","article-title":"The small nuclear ribonucleoprotein U1A interacts with NS5 from yellow fever virus","volume":"156","author":"Bronzoni","year":"2011","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0065","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JVI.73.4.3095-3101.1999","article-title":"Yellow fever\/Japanese encephalitis chimeric viruses: construction and biological properties","volume":"73","author":"Chambers","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0070","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.iy.13.040195.000333","article-title":"Hepatitis B virus immunopathogenesis","volume":"13","author":"Chisari","year":"1995","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0075","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/viro.2001.1255","article-title":"Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E","volume":"293","author":"Co","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0080","doi-asserted-by":"crossref","first-page":"13819","DOI":"10.1128\/JVI.78.24.13819-13828.2004","article-title":"Efficacy of DNA and fowlpox virus priming\/boosting vaccines for simian\/human immunodeficiency virus","volume":"78","author":"Dale","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0085","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1128\/JVI.74.12.5477-5485.2000","article-title":"Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates","volume":"74","author":"Guirakhoo","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0090","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/viro.1999.9695","article-title":"Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis","volume":"257","author":"Guirakhoo","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0095","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.vaccine.2010.11.079","article-title":"Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs","volume":"29","author":"Jiang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0100","first-page":"1101","article-title":"Flaviviridae: the viruses and their replication","volume":"vol. 5","author":"Lindenbach","year":"2007"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0105","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1128\/JVI.75.5.2107-2118.2001","article-title":"Yellow fever virus encephalitis: properties of the brain-associated T-cell response during virus clearance in normal and gamma interferon-deficient mice and requirement for CD4+ lymphocytes","volume":"75","author":"Liu","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0110","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/0042-6822(87)90141-3","article-title":"Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain)","volume":"161","author":"Lobigs","year":"1987","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0115","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.virol.2008.04.043","article-title":"Comprehensive analysis of T cell epitope discovery strategies using 17DD yellow fever virus structural proteins and BALB\/c (H2d) mice model","volume":"378","author":"Maciel","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0120","doi-asserted-by":"crossref","first-page":"e1000327","DOI":"10.1371\/journal.pcbi.1000327","article-title":"T-cell epitope prediction: rescaling can mask biological variation between MHC molecules","volume":"5","author":"MacNamara","year":"2009","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0125","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0130","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3201\/eid0706.010605","article-title":"Advanced age a risk factor for illness temporally associated with yellow fever vaccination","volume":"7","author":"Martin","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0135","doi-asserted-by":"crossref","first-page":"9197","DOI":"10.1128\/JVI.74.19.9197-9205.2000","article-title":"Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases","volume":"74","author":"McAllister","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0140","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nm881","article-title":"Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans","volume":"9","author":"McConkey","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0145","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.vaccine.2006.11.027","article-title":"Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases","volume":"25","author":"McMahon","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0150","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","article-title":"Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines","volume":"28","author":"Miller","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0155","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1128\/JVI.74.4.1742-1751.2000","article-title":"Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose\u2013response effectiveness and extended safety testing in rhesus monkeys","volume":"74","author":"Monath","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0160","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00251-010-0461-0","article-title":"The live-attenuated yellow fever vaccine 17D induces broad and potent T cell responses against several viral proteins in Indian rhesus macaques \u2013 implications for recombinant vaccine design","volume":"62","author":"Mudd","year":"2010","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1743-422X-8-127","article-title":"Biological and immunological characterization of recombinant Yellow Fever 17D viruses expressing a Trypanosoma cruzi Amastigote Surface Protein-2 CD8+ T cell epitope at two distinct regions of the genome","volume":"8","author":"Nogueira","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.152.1.163","article-title":"Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains","volume":"152","author":"Parker","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0175","first-page":"895","article-title":"Persistence of neutralizing antibody 30\u201335 years after immunization with 17D yellow fever vaccine","volume":"59","author":"Poland","year":"1981","journal-title":"Bull. World Health Organ."},{"issue":"Pt. 7","key":"10.1016\/j.jviromet.2012.10.002_bib0180","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1099\/0022-1317-78-7-1543","article-title":"Secondary structure of the 3\u2032-untranslated region of yellow fever virus: implications for virulence, attenuation and vaccine development","volume":"78","author":"Proutski","year":"1997","journal-title":"J. Gen. Virol."},{"issue":"Pt. 8","key":"10.1016\/j.jviromet.2012.10.002_bib0185","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1099\/0022-1317-71-8-1697","article-title":"Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b","volume":"71","author":"Putnak","year":"1990","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s002510050595","article-title":"SYFPEITHI: database for MHC ligands and peptide motifs","volume":"50","author":"Rammensee","year":"1999","journal-title":"Immunogenetics"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0195","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection","volume":"56","author":"Reinhardt","year":"1998","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0200","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.4023707","article-title":"Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution","volume":"229","author":"Rice","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0205","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.virol.2005.04.032","article-title":"Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus","volume":"337","author":"Rutigliano","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0210","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1128\/JVI.60.3.1153-1155.1986","article-title":"Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1","volume":"60","author":"Schlesinger","year":"1986","journal-title":"J. Virol."},{"issue":"Pt. 6","key":"10.1016\/j.jviromet.2012.10.002_bib0215","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1099\/0022-1317-77-6-1277","article-title":"Replication of yellow fever virus in the mouse central nervous system: comparison of neuroadapted and non-neuroadapted virus and partial sequence analysis of the neuroadapted strain","volume":"77","author":"Schlesinger","year":"1996","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0220","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1006\/viro.1993.1015","article-title":"The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice","volume":"192","author":"Schlesinger","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0225","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/infdis\/jiq074","article-title":"Development of antigen-specific memory CD8+ T cells following live-attenuated chimeric West Nile virus vaccination","volume":"203","author":"Smith","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"RR-7","key":"10.1016\/j.jviromet.2012.10.002_bib0230","first-page":"1","article-title":"Yellow Fever Vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"59","author":"Staples","year":"2010","journal-title":"MMWR"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0235","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1099\/0022-1317-82-7-1749","article-title":"Characterization of a new H-2D(k)-restricted epitope prominent in primary influenza A virus infection","volume":"82","author":"Tourdot","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0240","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1126\/science.8456302","article-title":"Heterologous protection against influenza by injection of DNA encoding a viral protein","volume":"259","author":"Ulmer","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0245","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/viro.2002.1432","article-title":"Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in mice","volume":"296","author":"van der Most","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0250","doi-asserted-by":"crossref","first-page":"8094","DOI":"10.1128\/JVI.74.17.8094-8101.2000","article-title":"Chimeric yellow fever\/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response","volume":"74","author":"van Der Most","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0255","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1006\/viro.1998.9564","article-title":"Noncytopathic flavivirus replicon RNA-based system for expression and delivery of heterologous genes","volume":"255","author":"Varnavski","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0260","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jviromet.2012.10.002_bib0265","first-page":"845","article-title":"The nursing care of Viscera Detriment following vaccination with 17D yellow fever vaccine: a report of one case","volume":"40","author":"Wang","year":"2005","journal-title":"Chin. Nurs. J."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0270","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1099\/0022-1317-83-1-75","article-title":"A DNA\/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques","volume":"83","author":"Wee","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0275","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1146\/annurev.immunol.23.021704.115702","article-title":"Understanding presentation of viral antigens to CD8+ T cells in vivo: the key to rational vaccine design","volume":"23","author":"Yewdell","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jviromet.2012.10.002_bib0280","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/1743-422X-8-263","article-title":"Identification of CD8+ cytotoxic T lymphocyte epitopes from porcine reproductive and respiratory syndrome virus matrix protein in BALB\/c mice","volume":"8","author":"Zhang","year":"2011","journal-title":"Virol. J."}],"container-title":["Journal of Virological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093412003606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166093412003606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T13:05:44Z","timestamp":1687784744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166093412003606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["S0166093412003606"],"URL":"https:\/\/doi.org\/10.1016\/j.jviromet.2012.10.002","relation":{},"ISSN":["0166-0934"],"issn-type":[{"value":"0166-0934","type":"print"}],"subject":[],"published":{"date-parts":[[2013,2]]}}}